|
Volumn 19, Issue 2, 2011, Pages 900-906
|
Design, synthesis and biological evaluation of novel l-lysine ureido derivatives as aminopeptidase N inhibitors
|
Author keywords
Aminopeptidase N inhibitor; l Lysine ureido derivatives; Synthesis
|
Indexed keywords
6 BENZYLOXYCARBONYLAMINO 2 (3 CARBOXYMETHYL UREIDO) HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 (3 METHOXYCARBONYL METHYL UREIDO) HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 BENZYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 BENZYL) UREIDO] HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 METHYL BUTYL) UREIDO] HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 METHYL PROPYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 METHYL PROPYL) UREIDO] HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 2 METHYLBUTYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 3 METHYL BUTYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 3 METHYLBUTYL) UREIDO] HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 3 METHYLSULFANYL PROPYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY 3 METHYLSULFANYL PROPYL) UREIDO] HEXANOIC ACID METHYL ESTER;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY ETHYL) UREIDO] HEXANOIC ACID;
6 BENZYLOXYCARBONYLAMINO 2 [3 (1 CARBOXY ETHYL) UREIDO] HEXANOIC ACID METHYL ESTER;
[5 HYDROXYCARBAMOYL 5 (3 HYDROXYCARBAMOYLMETHY UREIDO) PENTYL] CARBAMIC ACID BENZYL ESTER;
BESTATIN;
LYSINE DERIVATIVE;
LYSINE UREIDO DERIVATIVE;
PEPTIDE HYDROLASE INHIBITOR;
UNCLASSIFIED DRUG;
{5 HYDROXYCARBAMOYL 5 [3 (1 HYDROXYCARBAMOYL 2 METHYL BUTYL) UREIDO] PENTYL} CARBAMIC ACID BENZYL ESTER;
{5 HYDROXYCARBAMOYL 5 [3 (1 HYDROXYCARBAMOYL 2 PHENY ETHYL) UREIDO] PENTYL} CARBAMIC ACID BENZYL ESTER;
{5 HYDROXYCARBAMOYL 5 [3 (1 HYDROXYCARBAMOYL 3 METHYL BUTYL) UREIDO] PENTYL} CARBAMIC ACID BENZYL ESTER;
{5 HYDROXYCARBAMOYL 5 [3 (1 HYDROXYCARBAMOYL 3 METHYLSULFANYL PROPYL) UREIDO] PENTYL} CARBAMIC ACID BENZYL ESTER;
{5 HYDROXYCARBAMOYL 5 [3 (1 HYDROXYCARBAMOYL ETHY) UREIDO] PENTYL} CARBAMIC ACID BENZYL ESTER;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG INHIBITION;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FEMALE;
HUMAN;
HUMAN CELL;
ANTIGENS, CD13;
ANTINEOPLASTIC AGENTS;
BINDING SITES;
CELL LINE, TUMOR;
COMPUTER SIMULATION;
DRUG DESIGN;
HUMANS;
HYDROGEN BONDING;
LEUCINE;
LYSINE;
PHENYLUREA COMPOUNDS;
PROTEASE INHIBITORS;
PROTEIN STRUCTURE, TERTIARY;
STRUCTURE-ACTIVITY RELATIONSHIP;
UREA;
|
EID: 78651480502
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.11.066 Document Type: Article |
Times cited : (15)
|
References (13)
|